Anthropic announced Monday that it has confidentially filed paperwork to go public as it scrambles to beat top rival OpenAI to a Wall Street debut.

The company, led by CEO Dario Amodei, filed its required S-1 form with the US Securities and Exchange Commission just days after it raised $65 billion at a post-money valuation of $965 billion – making it more valuable than OpenAI.

“The number of shares to be offered and the price have not yet been set,” Anthropic said in a press release.

The firm did not comment on the potential timing of its debut, stating only that it will “depend on market conditions and other factors.” Recent reports said it could debut on Wall Street by this fall.

The public offering has major implications for the race to developed advanced AI. It is considered a litmus test for tech giants that have poured tens of billions of dollars into the technology.

Anthropic has recently seen massive demand for its Claude chatbot following the unveiling of its much-hyped “Mythos” model.

OpenAI is said to be days away from its own confidential IPO filing and is reportedly eyeing a fall debut on public markets.

Anthropic is also competing with Elon Musk’s SpaceX, which is aiming to raise a record $75 billion at a $1.75 trillion valuation in its own public debut. SpaceX is the parent company of Musk’s xAI, best known as the creator of the “Grok” chatbot.

Anthropic triggered alarms in April while warning that Mythos was too powerful to be released to the public because it had “found thousands of high-severity vulnerabilities, including some in every major operating system and web browser.”

The AI firm instead made Mythos available to a few dozen corporate partners as part of a pilot program, though it has since confirmed that a public rollout is coming soon.

As The Post reported, some critics have alleged that the company’s warnings for Mythos were actually a carefully orchestrated campaign to build hype about the model – and to mask the company’s struggles to find sufficient tech resources to serve Mythos to mass-market customers.